Type and number of risk periods experienced by the children during follow-up according to their deficiency status
| Type of risk period . | AT (2) . | PC (4) . | PS (2) . | F V Leiden (11) . | G20210A (2) . | Noncarriers (15) . |
|---|---|---|---|---|---|---|
| Trauma | 1 | 4 [1] | 13 [2] | 3 | 15 | |
| Surgery | 1 | 1 | 1 | 4 | ||
| Immobilization | 3 | 2 | 2 | 1 | ||
| Total | 31[3] | 20 | ||||
| Type of risk period . | AT (2) . | PC (4) . | PS (2) . | F V Leiden (11) . | G20210A (2) . | Noncarriers (15) . |
|---|---|---|---|---|---|---|
| Trauma | 1 | 4 [1] | 13 [2] | 3 | 15 | |
| Surgery | 1 | 1 | 1 | 4 | ||
| Immobilization | 3 | 2 | 2 | 1 | ||
| Total | 31[3] | 20 | ||||
Numbers in parentheses indicate the number of children who experienced risk periods.
Numbers in brackets indicate the number of risk periods during which prophylaxis was given.
AT indicates antithrombin defect; PC, protein C defect; PS, protein S defect; F V Leiden, factor V Leiden mutation; G20210A, prothrombin gene mutation.